(19)
(11) EP 0 973 727 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
18.01.2006 Bulletin 2006/03

(45) Mention of the grant of the patent:
26.10.2005 Bulletin 2005/43

(21) Application number: 98917555.9

(22) Date of filing: 10.04.1998
(51) International Patent Classification (IPC): 
C07C 233/78(1990.01)
C07D 311/16(1985.01)
C07D 277/58(1985.01)
C07D 213/81(1985.01)
C07C 237/30(1990.01)
C07D 285/135(1990.01)
A61K 31/44(1985.01)
A61K 31/35(1985.01)
 A61K 31/165(1985.01)
C07D 277/46(1985.01)
C07C 233/65(1990.01)
C07D 213/82(1985.01)
C07D 277/56(1985.01)
A61K 31/425(1985.01)
A61K 31/55(1985.01)
(86) International application number:
PCT/IB1998/000768
(87) International publication number:
WO 1998/045253 (15.10.1998 Gazette 1998/41)

(54)

ACTIVATED IODODERIVATIVES FOR THE TREATMENT OF CANCER AND AIDS

AKTIVIERTE IOD-VERBINDUNGEN ZUR BEHANDLUNG VON KREBS UND AIDS

DERIVES D'IODE ACTIVES UTILISES DANS LE TRAITEMENT DU CANCER ET DU SIDA

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 10.04.1997 US 43360 P

(43) Date of publication of application:
26.01.2000 Bulletin 2000/04

(73) Proprietor: Isotechnika International, Inc.
Belleville Saint Michael (BB)

(72) Inventors:
  • YATSCOFF, Randall, W.
    Edmonton, Alberta T6R 2B7 (CA)
  • FOSTER, Robert, T.
    Edmonton, Alberta T6J 1X9 (CA)
  • NAICKER, Selvaraj
    Edmonton, Alberta T6J 3J4 (CA)

(74) Representative: Nash, David Allan et al
HASELTINE LAKE, Redcliff Quay 120 Redcliff Street
Bristol BS1 6HU
Bristol BS1 6HU (GB)


(56) References cited: : 
WO-A-96/22791
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).